Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33+0.04 (+3.10%)
Close on Nov 16, 2026Market cap $4.86MP/E –Yield –
Pulmatrix profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pulmatrix's profit margin for the twelve months ending Dec 31, 2024 was -122.5%. For fiscal 2024 it was -122.5%, against -193.5% the year before. The highest annual figure on record is -122.5% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -122.5% | +71.0 |
| FY2023 | Dec 31, 2023 | -193.5% | +116.8 |
| FY2022 | Dec 31, 2022 | -310.3% | +80.0 |
| FY2021 | Dec 31, 2021 | -390.2% | −237.4 |
| FY2020 | Dec 31, 2020 | -152.8% | +107.6 |
| FY2019 | Dec 31, 2019 | -260.4% | +13179.5 |
| FY2018 | Dec 31, 2018 | -13439.9% | −8050.0 |
| FY2017 | Dec 31, 2017 | -5389.9% | −2055.4 |
| FY2016 | Dec 31, 2016 | -3334.5% | −1155.7 |
| FY2015 | Dec 31, 2015 | -2178.8% | +4680.3 |
| FY2014 | Dec 31, 2014 | -6859.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -66200.0% | −66105.4 |
| Q3 FY2024 | Sep 30, 2024 | -706.8% | −491.5 |
| Q2 FY2024 | Jun 30, 2024 | -374.4% | −167.5 |
| Q1 FY2024 | Mar 31, 2024 | 14.0% | +310.7 |
| Q4 FY2023 | Dec 31, 2023 | -94.6% | +152.2 |
| Q3 FY2023 | Sep 30, 2023 | -215.3% | +54.6 |
| Q2 FY2023 | Jun 30, 2023 | -206.9% | +138.3 |
| Q1 FY2023 | Mar 31, 2023 | -296.7% | +132.0 |
| Q4 FY2022 | Dec 31, 2022 | -246.8% | +637.2 |
| Q3 FY2022 | Sep 30, 2022 | -269.9% | +495.7 |
| Q2 FY2022 | Jun 30, 2022 | -345.2% | −174.3 |
| Q1 FY2022 | Mar 31, 2022 | -428.7% | −133.5 |
| Q4 FY2021 | Dec 31, 2021 | -884.0% | −739.0 |
| Q3 FY2021 | Sep 30, 2021 | -765.6% | −524.2 |
| Q2 FY2021 | Jun 30, 2021 | -170.9% | −137.5 |
| Q1 FY2021 | Mar 31, 2021 | -295.3% | −125.6 |
| Q4 FY2020 | Dec 31, 2020 | -144.9% | +94.9 |
| Q3 FY2020 | Sep 30, 2020 | -241.4% | +11.5 |
| Q2 FY2020 | Jun 30, 2020 | -33.4% | +129.3 |
| Q1 FY2020 | Mar 31, 2020 | -169.7% | +3242.8 |
| Q4 FY2019 | Dec 31, 2019 | -239.8% | +3172.6 |
| Q3 FY2019 | Sep 30, 2019 | -252.8% | +1076.1 |
| Q2 FY2019 | Jun 30, 2019 | -162.8% | +8238.9 |
| Q4 FY2018 | Dec 31, 2018 | -3412.4% | – |
| Q1 FY2018 | Mar 31, 2018 | -3412.4% | – |
| Q3 FY2017 | Sep 30, 2017 | -1329.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -8401.7% | – |
See a number that looks wrong?